Comparison of the efficacy of two different glucocorticoid regimens for treatment of active moderate-to-severe Graves’ orbitopathy

被引：0
作者：
Mariya Asenova Stoynova
Alexander Dimitrov Shinkov
Inna Dimitrova Dimitrova
Inna Angelova Yankova
Roussanka Dimitrova Kovatcheva
机构：
[1] Medical University of Sofia,Department of Endocrinology
[2] University Hospital of Endocrinology,undefined
来源：
International Ophthalmology | 2023年 / 43卷
关键词：
Graves’ orbitopathy; Glucocorticoid regimens; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4747 / 4757
页数：10
相关论文
共 50 条
[41]   Commentary: Efficacy and safety of intravenous monoclonal antibodies in patients with moderate-to-severe active Graves' ophthalmopathy: a systematic review and meta-analysis [J].
Li, Lingxiao ;
Wu, Jihong .
FRONTIERS IN ENDOCRINOLOGY, 2024, 15
[42]   Tapentadol for the Treatment of Moderate-to-Severe Acute Pain in Children Under the Age of Two Years [J].
Eissa, Ayman ;
Tarau, Eva ;
Beuter, Christoph ;
Radic, Tatjana ;
Watson, Estelle ;
Sohns, Melanie ;
Lefeber, Claudia ;
Hammer, Gregory B. .
JOURNAL OF PAIN RESEARCH, 2021, 14 :229-248
[43]   Racial/ethnic differences in treatment efficacy and safety for moderate-to-severe plaque psoriasis: a systematic review [J].
Ferguson, Jessica E. ;
Seger, Edward W. ;
White, Jacob ;
McMichael, Amy .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2023, 315 (01) :41-50
[44]   Racial/ethnic differences in treatment efficacy and safety for moderate-to-severe plaque psoriasis: a systematic review [J].
Jessica E. Ferguson ;
Edward W. Seger ;
Jacob White ;
Amy McMichael .
Archives of Dermatological Research, 2023, 315 :41-50
[45]   Dosimetric comparison of lateral opposing fields in moderate-to-severe active TAO retro-orbital irradiation [J].
Nan, X. X. ;
Shi, X. J. ;
Hou, Y. J. ;
Zhang, H. M. ;
Zhang, J. ;
Li, X. F. ;
Gao, Y. Y. .
INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2021, 19 (02) :443-450
[46]   Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy [J].
Napolitano, Maria ;
D'Amico, Ferdinando ;
Ragaini, Elisa ;
Peyrin-Biroulet, Laurent ;
Danese, Silvio .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 :1897-1913
[47]   Comparison of Efficacy and Safety Outcomes of Different Doses Schedules of Thalidomide for Treating Moderate-to-Severe f-Thalassemia Patients [J].
Yang, Wei-Jia ;
Shi, Lian-dong ;
Liang, Ye ;
Liang, Li-ming ;
Zhang, Hao ;
Wang, Li ;
Zhou, Qian .
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2024, 20 :799-809
[48]   Efficacy and safety of lebrikizumab for the treatment of moderate-to-severe atopic dermatitis: a systematic review and meta-analysis [J].
Lin, Jinger ;
Luo, Min ;
Zhuo, Qianwei ;
Chen, Nuo ;
Zhang, Haosong ;
Han, Yue .
FRONTIERS IN PHARMACOLOGY, 2024, 15
[49]   Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study [J].
Chen, Baili ;
Zhong, Jie ;
Li, Xiuling ;
Pan, Feng ;
Ding, Yijuan ;
Zhang, Yan ;
Chen, Hong ;
Liu, Fei ;
Zhang, Zhenyu ;
Zhang, Ling ;
Drozda, Rafal ;
Oliinyk, Oleksandr ;
Goh, Aik Han ;
Chen, Xiang ;
Sun, Xiang ;
Rubin, David T. ;
Sandborn, William J. ;
Chen, Minhu .
GASTROENTEROLOGY, 2022, 163 (06) :1555-1568
[50]   The efficacy and immunological effects of upadacitinib in the treatment of moderate-to-severe Chinese atopic dermatitis patients [J].
Li, Lu ;
Wu, Naming ;
Liu, Tingyu ;
Yu, Guoqun ;
Wang, Yifei ;
He, Ting ;
Mao, Raymond ;
Yang, Liu ;
Li, Yan ;
Shen, Chen ;
Tao, Juan .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 125
12345